by Michael Levin
Michael D. Levin, founder of Health Business Strategies, LLC, Clackamas, Oregon, encourages practitioners to fight against the move by the New York Attorney General to remove dietary supplements from the shelves of major retailers.
by Mark Davis, ND
A recent study inoculated celiac disease patients with hookworm larvae, and the results were promising. Could it be that the human gut’s “old friend,” the hookworm, holds the key to treating celiac disease?
by Kate Rhéaume-Bleue, ND
In a recent study, researchers observed that milk consumption had a deleterious effect on mortality and fracture risk, but that fermented dairy products did not. Given that milk and fermented dairy products have vastly different nutritional profiles, practitioners would be well advised to reconsider how they talk to patients about dairy in the diet.
by Jaclyn Chasse, ND
In this study, men with fertility problems were shown to be more likely to also suffer from endocrine, genitourinary, and dermatological disorders. The study reminds us that treating patients for infertility may often mean treating other “unrelated” health issues.
by Peter Bongiorno, ND, LAc
In this Taiwanese study, researchers found that adding omega-3 fatty acids to the diet of patients undergoing interferon-alpha therapy decreased their depressive symptoms significantly.
by Natural Medicine Journal
Respected naturopathic oncologist Michael Traub, ND, FABNO, provides an updated overview of fermented wheat germ extract. In addition to discussing specific research studies, Traub explains contraindications, dosage, and some of the pros and cons of this unique natural substance.
by Karolyn A. Gazella
Daniel Church, PhD, has been president of Bastyr University, Kenmore, Washington, since 2005. As he prepares for retirement at the end of this school year, he takes a candid look back and a thoughtful look forward as he comments about his tenure as president and the future of naturopathic medicine.
by Elizabeth Mumper, MD
Autism spectrum disorder (ASD), a disorder characterized by social, communication, and behavioral impairments, has increased dramatically in recent years. The conventional medical paradigm defines ASD as a neurological disorder. Conventional treatments rely on behavioral therapies and psychotropic medications but have limited success and tolerability. A new paradigm is emerging that views ASD as a multisystem disorder accompanied by metabolic and mitochondrial impairments. A clinical approach to assess and treat metabolic dysfunction in ASD is reviewed here.